Article
Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Trends in molecular medicine - 1 May 2024
Elitt Matthew S, Tesar Paul J
Abstract excerpt
Pelizaeus-Merzbacher disease (PMD) is caused by mutations in the proteolipid protein 1 (PLP1) gene encoding proteolipid protein (PLP). As a major component of myelin, mutated PLP causes progressive neurodegeneration and eventually death due to severe white matter deficits. Medical care has long been limited to symptomatic treatments, but first-in-class PMD therapies with novel mechanisms now stand poised to enter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
